Method for quantitatively detecting volatile organic compounds in biological sample by using comprehensive two-dimensional gas chromatograph-mass spectrometer

CN118914383APending Publication Date: 2024-11-08SUZHOU BIONOVOGENE BIOMEDICAL TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410815856.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-06-24
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The prior art is difficult to detect various volatile organic compounds in biological samples at the same time, and the lack of corresponding standards or reference products, resulting in limited number of detection types.

Method used

Using a full two-dimensional gas chromatography-mass spectrometry combination, the correction factor was calculated by determining the combination of reference compounds and the combination of internal standard compounds, and the quantitative detection of target volatile organic compounds in biological samples was achieved.

Benefits of technology

The simultaneous detection of various volatile organic compounds in biological samples is achieved, which reduces the detection cost and improves the accuracy of the detection results and the simplicity of operation.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118914383A_ABST
    Figure CN118914383A_ABST
Patent Text Reader

Abstract

The invention discloses a method for quantitatively detecting volatile organic compounds in a biological sample by a comprehensive two-dimensional gas chromatograph-mass spectrometer. The method comprises the following steps: determining a reference substance compound combination and an internal standard compound combination according to the biological sample; providing a mixed reference substance solution comprising a reference substance compound combination, a mixed internal standard solution comprising an internal standard compound combination, and a biological sample; respectively adding the mixed internal standard solution into the mixed reference substance solution and the biological sample to obtain an on-machine sample; respectively feeding the on-machine samples into a comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometer for determination to obtain off-machine data, and processing the off-machine data to obtain reference substance data and biological sample data; calculating a correction factor of each reference substance compound in the mixed reference substance solution according to the reference substance data; determining a reference substance compound and an internal standard compound corresponding to the target volatile organic compound in the biological sample; and calculating the concentration of the target volatile organic compound according to a concentration formula.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of volatile organic compound detection, and in particular to a method for quantitatively detecting volatile organic compounds in biological samples by using a comprehensive two-dimensional gas chromatography-mass spectrometry instrument. Background Art

[0002] Volatile organic compounds (VOCs) are a class of volatile compounds that are commonly found in the environment. Some VOCs are harmful to human health. After VOCs enter the human body through the respiratory tract and skin, some enter the blood circulation system to undergo metabolic reactions, and some are excreted from the body in their original form with urine. At the same time, the body's own metabolic process can also produce VOCs. By detecting VOCs in the body, the impact of the external environment on the body's metabolism can be reflected. Some VOCs are also potential biomarkers for disease diagnosis, and detecting these VOCs can assist in disease diagnosis.

[0003] Existing methods mostly detect or monitor VOCs in the environment, and rarely VOCs in biological samples. VOCs in biological samples often contain a large number of compounds, some of which are difficult to synthesize or have high synthesis costs, are difficult to obtain, etc., so it is impossible to provide corresponding identical standards or references for each compound. Therefore, when detecting VOCs in biological samples, existing technologies often cannot achieve simultaneous quantitative detection of multiple VOCs or the number of detected types is small. Summary of the invention

[0004] The technical problem to be solved by the embodiments of the present invention is to provide a method for quantitatively detecting volatile organic compounds in biological samples using a comprehensive two-dimensional gas chromatography-mass spectrometry instrument, which can simultaneously detect multiple VOCs in biological samples.

[0005] In order to solve the above technical problems, the present invention provides a method for quantitatively detecting volatile organic compounds in biological samples by using a comprehensive two-dimensional gas chromatography-mass spectrometry instrument, the method comprising the following steps: determining a reference compound combination and an internal standard compound combination according to the biological sample; providing a mixed reference solution including the reference compound combination, a mixed internal standard solution including the internal standard compound combination, and a biological sample; adding the mixed internal standard solution to the mixed reference solution and the biological sample, respectively, to obtain an on-machine sample; respectively entering the on-machine sample into a comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry instrument for measurement to obtain off-machine data, and obtaining reference product data and biological sample data after data processing; calculating a correction factor of each reference product compound in the mixed reference product solution according to the reference product data; determining the reference product compound and the internal standard compound corresponding to the target volatile organic compound in the biological sample; and calculating the concentration of the target volatile organic compound according to a concentration formula, the concentration formula being as follows: C (n) =P n / P ns' *RF (n) *C ns Where, C (n) : The concentration of target volatile organic compounds; P n : Mass spectrometry response of target volatile organic compounds; P ns' : Mass spectrometric response of the internal standard compound corresponding to the target volatile organic compound; RF (n) : Correction factor of the reference compound corresponding to the target volatile organic compound; C ns : The concentration of the internal standard compound corresponding to the target volatile organic compound.

[0006] In a feasible embodiment, the operation of determining the reference compound and internal standard compound corresponding to the target volatile organic compound in the biological sample includes the following steps: when the mixed reference solution contains a first reference compound that is the same as the target volatile organic compound, the internal standard of the first reference compound is selected as the internal standard of the target volatile organic compound, and the correction factor of the first reference compound is the correction factor of the target volatile organic compound.

[0007] In a feasible embodiment, the operation of determining the reference compound and internal standard compound corresponding to the target volatile organic compound in the biological sample includes the following steps: when the mixed reference solution does not contain the same compound as the target volatile organic compound, according to the biological sample data, in the mixed reference combination according to a first predetermined condition, select a compound whose mass spectrum data and / or chemical structure is closest to the target volatile organic compound as a second reference compound, then the internal standard of the second reference compound is the internal standard of the target volatile organic compound, and the correction factor of the second reference compound is the correction factor of the target volatile organic compound.

[0008] In a feasible embodiment, the method of determining the reference compound and the internal standard compound based on the biological sample includes the following steps: obtaining a preselected reference compound and a preselected internal standard based on the target organic volatiles; taking the preselected reference compound and the preselected internal standard, diluting them step by step, and preparing a mixed solution of a series of concentrations; entering the mixed solution into the comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometer for measurement to obtain mass spectrometry offline data, and constructing a linear relationship curve between the concentration and mass spectrometry response of each preselected reference compound and the preselected internal standard based on the mass spectrometry offline data; calculating the correction factor of each preselected reference compound and each preselected internal standard; and determining the reference compound combination and the internal standard compound combination based on the linear relationship curve and the correction factor.

[0009] In a feasible embodiment, the operation of determining the reference compound combination and the internal standard compound combination based on the linear relationship curve and the correction factor includes the following steps: retaining the preselected reference compounds and preselected internal standards whose linear relationship curves and correction factors meet preselected conditions, and the preselected conditions include: the linear correlation coefficient of the linear relationship curve is greater than 0.99 and at least one correction factor is in the range of 0.1-10.

[0010] In a feasible implementation manner, the operation of determining the reference compound and the internal standard compound according to the linear relationship curve and the correction factor further includes the following steps: determining the internal standard compound corresponding to the reference compound according to a preset value of the correction factor.

[0011] In a feasible embodiment, the mixed reference solution includes one or more of a benzene ring compound reference, an aldehyde reference, an alcohol reference, a ketone reference, a hydrocarbon reference, a heterocyclic compound reference and a lipid compound reference.

[0012] In a feasible embodiment, the benzene ring compound reference substance is selected from at least one of eugenol, p-methylphenol, 4-tert-butylphenol, 2-methoxy-4-vinylphenol, phenol, p-isopropyltoluene, 1,3-di-tert-butylbenzene, methylnaphthalene, p-cymene and anisole; the aldehyde reference substance is selected from at least one of α-methylcinnamaldehyde, hexanal, benzaldehyde, octanal, decanal, nonanal and 2-aminobenzaldehyde; the alcohol reference substance is selected from at least one of 1-decanol, 1-octanol, tetradecanol, cis-9-hexadecanol and cholestyrene. The ketone reference substance is selected from at least one of 4-heptanone, 3-methyl-2-pentanone, ethyl isobutyl ketone, 2-pentanone, 2-nonanone and cyclohexanone; the hydrocarbon reference substance is selected from at least one of trans-2-decenoic acid and n-decane; the heterocyclic compound reference substance is selected from at least one of 2,5-dimethylpyrazine, N-ethyl pyridine bromide, proline, indole, 2,7-dimethylquinoline and 2-n-pentylfuran; the lipid compound reference substance is selected from at least one of methyl palmitate and ethyl acetate.

[0013] In a feasible embodiment, the internal standard compound in the mixed reference substance is selected from at least one of menthol-d4, 4-methyl-2-pentanone-d5, p-cresol-d3, and benzonitrile-d5.

[0014] In a feasible implementation manner, the corresponding relationship between the reference compound and the internal standard compound is shown in the following table:

[0015]

[0016] In a feasible embodiment, the biological sample is selected from at least one of urine, serum and feces.

[0017] In a feasible implementation, the comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometer model is: Agilent 8890A gas chromatograph + Leco Pegasμs BT 4D TOFMS mass spectrometer + QUADJET GC×GC two-stage injection modulator. The implementation of the present invention has the following beneficial effects:

[0018] The method provided in the present application for quantitatively detecting volatile organic compounds in biological samples by using a comprehensive two-dimensional gas chromatography-mass spectrometry instrument only needs to find the corresponding correction factor of the target volatile organic compound during detection, and can simultaneously perform quantitative detection on a large number of volatile organic compounds in the biological sample based on the corresponding correction factor and the internal standard without requiring a large number of reference substances. The detection results are accurate, the detection cost is reduced, and the method is simple to operate. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] Figure 1It is a schematic flow chart of a method for quantitatively detecting volatile organic compounds in biological samples using a comprehensive two-dimensional gas chromatography-mass spectrometry instrument in the present application;

[0020] Figure 2 is a two-dimensional chromatogram of the detection of volatile organic compounds in a urine sample in Example 1;

[0021] Figure 3 is a three-dimensional chromatogram of the detection of volatile organic compounds in a urine sample in Example 1;

[0022] Figure 4 is a two-dimensional chromatogram of the detection of volatile organic compounds in serum samples in Example 2;

[0023] Figure 5 is a three-dimensional chromatogram of the detection of volatile organic compounds in serum samples in Example 2;

[0024] Figure 6 is a two-dimensional chromatogram of the detection of volatile organic compounds in fecal samples in Example 3;

[0025] Figure 7 This is a three-dimensional chromatogram of the detection of volatile organic compounds in fecal samples in Example 3. DETAILED DESCRIPTION

[0026] In order to make the above-mentioned objects, features and advantages of the present invention more obvious and easy to understand, the specific embodiments of the present invention are described in detail below in conjunction with the accompanying drawings. In the following description, many specific details are set forth to facilitate a full understanding of the present invention. However, the present invention can be implemented in many other ways different from those described herein, and those skilled in the art can make similar improvements without violating the connotation of the present invention, so the present invention is not limited by the specific embodiments disclosed below.

[0027] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those commonly understood by those skilled in the art of the present invention. The terms used herein in the specification of the present invention are only for the purpose of describing specific embodiments and are not intended to limit the present invention. The term "and / or" used herein includes any and all combinations of one or more related listed items.

[0028] The present application embodiment provides a method for quantitatively detecting volatile organic compounds in biological samples using a comprehensive two-dimensional gas chromatography-mass spectrometer. The method includes steps S110 to S170, and the specific steps are as follows:

[0029] S110. Determine a reference compound combination and an internal standard compound combination according to the biological sample.

[0030] In an optional implementation, step S110 includes steps S111-S116, and the specific steps are as follows:

[0031] S111. Obtain a preselected reference substance and a preselected internal standard according to the target organic volatiles.

[0032] You can consult existing literature and / or test biological samples to obtain target volatile organic compounds that may exist in biological samples, and select corresponding pre-selected reference substances and pre-selected internal standards based on these possible target organic volatiles. The existing literature here includes any form of public information such as databases, journals, and papers that can be queried. For example, through existing literature, you can obtain volatile organic compounds that may exist and be detected in biological samples, and then collect different biological samples for testing to confirm whether these volatile organic compounds can be detected, and further consider whether the reference substances are available. In this way, we can obtain about 42 pre-selected reference substances and 10 pre-selected internal standards. The 42 pre-selected reference substances are: 1-octanol, n-decanol, tetradecanol, cis-9-hexenol, cholesterol, 4-heptanone, 3-methyl-2-pentanone, ethyl isobutyl ketone (5-methyl-3-hexanone), 2-pentanone, 2-nonanone, cyclohexanone, butanone. Eugenol, p-cresol, 4-tert-butylphenol, 2-methoxy-4-vinylphenol, phenol, octanal, benzaldehyde, hexanal, a-methylcinnamaldehyde, decanal, nonanal, 2-aminobenzaldehyde, β-ocimene, trans-2-decenoic acid, n-decane, p-isopropyl toluene, ethyl acetate, 1,3-di-tert-butylbenzene, methylnaphthalene, 2,5-dimethylpyrazine, N-pyridine bromide, proline, indole, 2,7-dimethylquinoline, anisole, methyl palmitate, N-phenylformamide, dimethyl trisulfide, dimethyl disulfide, n-octanoic acid, 2-n-pentylfuran. The 10 preselected internal standards are: menthol-d4, 4-methyl-2-pentanone-d5, p-cresol-d3, deuterated acetaldehyde-d4, benzonitrile-d5, deuterated octanoic acid-d3, dimethyl trisulfide-d6, ethyl acetate-d3, o-xylene-d4, and tetrahydrofuran-d8.

[0033] S112, taking the preselected reference substance and the preselected internal standard, diluting them step by step, and preparing mixed solutions of a series of concentrations.

[0034] The preselected reference substance and the preselected internal standard are dissolved, mixed, diluted, and a series of mixed solutions with different concentrations are prepared. Mixed solutions with multiple concentration points (≥5 concentration points) can be prepared in a larger range according to the instrument detection range and the detection results of the biological sample.

[0035] S113, placing the mixed solution into the comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometer for measurement to obtain mass spectrum data.

[0036] Compared with the traditional one-dimensional gas chromatography-time of flight mass spectrometry, comprehensive two-dimensional gas chromatography-time of flight mass spectrometry has the advantages of high peak capacity (under the same analysis time and detection limit, the peak capacity of comprehensive two-dimensional gas chromatography-time of flight mass spectrometry can reach 10 times that of traditional one-dimensional chromatography), high resolution (good separation effect), high sensitivity (the modulator enriches and releases the co-eluting components, which can obtain higher sensitivity), family separation (the peaks of homologous series on the spectrum have a certain regularity). The use of comprehensive two-dimensional gas chromatography-time of flight mass spectrometry can detect more volatile organic compounds in biological samples and achieve better separation, thereby reducing interference and making quantitative results more accurate.

[0037] S114. According to the mass spectrometer offline data, a linear relationship curve between the concentration and mass spectrometer response of each preselected reference compound and preselected internal standard is constructed respectively.

[0038] The stability of the test results of the comprehensive two-dimensional gas chromatography-time of flight mass spectrometry is relatively poor due to its high sensitivity and the large number of detected substances. In addition, when using the comprehensive two-dimensional gas chromatography-time of flight mass spectrometry, liquid direct injection, liquid-liquid microextraction (LLME) or solid phase microextraction (SPME) can be used. Considering the ease of operation, detection of more substances and better reflection of the original characteristics of the sample to be tested, SPME is preferred. However, the extraction head is selective for the adsorption of volatile organic compounds, and the repeatability of adsorption is relatively poor, which further affects the stability of the final test results. In order to ensure the accuracy and stability of the test results, we conducted a large number of experiments to obtain stable reference compounds and internal standard compounds.

[0039] S115. Calculate the correction factor for each preselected reference substance and each preselected internal standard respectively.

[0040] S116. Determine the reference compound combination and the internal standard compound combination according to the linear relationship curve and the correction factor.

[0041] The operation of determining the reference compound combination and the internal standard compound combination according to the linear relationship curve and the correction factor comprises the following steps:

[0042] Preselected reference substances and preselected internal standards whose linear relationship curves and correction factors satisfy preselected conditions are retained, wherein the preselected conditions include: a linear correlation coefficient of the linear relationship curve>0.99 and at least one correction factor within the range of 0.1-10.

[0043] For example, a mixed solution containing the above 42 pre-selected reference substances and 10 pre-selected internal standards with a series of concentrations was prepared, and the solution was measured by a comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometer, and the concentration-mass spectrometry response linear relationship curve of each compound was constructed, and repeated three times. The results showed that: 1. A small number of compounds were not detected, such as n-octanoic acid and deuterated octanoic acid-d3; 2. The detection results of some compounds had poor repeatability, such as dimethyl trisulfide, dimethyl disulfide, and dimethyl trisulfide-d6; 3. The linear range of some compounds was narrow or non-linear (linear correlation coefficient <0.99), such as ethyl acetate, ethyl acetate-d3, tetrahydrofuran-d8, deuterated acetaldehyde-d4, etc. Therefore, these compounds were eliminated from the pre-selected reference substances and pre-selected internal standards.

[0044] Calculate the correction factor for each preselected reference substance and each preselected internal standard separately. If the correction factor is too large or too small, it means that the mass spectrometric response of the compound and the internal standard is very different, and the result of the internal standard quantification is inaccurate. Eliminate all preselected reference substances with correction factors greater than 10 or less than 0.1, such as β-ocimene, and calculate the correction factor for it and the preselected internal standard separately, as shown in the following table:

[0045]

[0046] It can be seen from the above table that the correction factors of β-ocimene are all much greater than 10, so β-ocimene is eliminated.

[0047] Furthermore, the operation of determining the reference compound and the internal standard compound according to the linear relationship curve and the correction factor also includes the following steps:

[0048] The internal standard compound corresponding to the reference compound is determined according to the preset value of the correction factor.

[0049] Specifically, the correction factor is preset to 1, and the internal standard compound with the correction factor closest to 1 is selected as the internal standard of the reference compound. The correction factor represents the proportional relationship between the mass spectrometer response intensity of the internal standard and the compound to be tested during the analysis process. When the correction factor is close to 1, it means that the response behavior of the internal standard and the reference compound under the instrument detection conditions is similar, and the response difference between the two is minimal. In this way, when using the internal standard method for quantitative analysis, the quantitative error caused by the response difference will be effectively reduced, thereby improving the accuracy of the analysis results. The reference compound and internal standard obtained and the corresponding relationship are as follows:

[0050]

[0051] Note: *The correction factor here is measured in Example 2 below.

[0052] It should be noted that the above correction factors may fluctuate under different comprehensive two-dimensional gas chromatography-mass spectrometry conditions and between different laboratories, and the corresponding relationship and correction factor may be different. In order to better ensure the accuracy of the test results, the mixed reference solution can be tested each time the test is carried out to calculate the correction factor value.

[0053] S120, providing a mixed reference solution including the reference compound combination, a mixed internal standard solution including the internal standard compound combination, and a biological sample.

[0054] Here, the reference compound combination refers to a compound used as a reference. When preparing a solution containing the reference compound combination, one compound in the reference compound combination with a known content or concentration can be used.

[0055] In an optional embodiment, the biological sample is a human or animal sample, which can be one or more of serum, plasma, urine, feces, and saliva. In the detection process of these human or animal samples, we found that the volatile organic compounds in these samples mainly include: benzene ring compounds, alcohols, aldehydes, hydrocarbons, ketones, heterocyclic compounds, lipids and lipid molecules. For example, a total of 746 volatile organic compounds in urine were detected by comprehensive two-dimensional gas chromatography-mass spectrometry, including 78 benzene ring compounds (aromatic compounds), 71 alcohols, 31 aldehydes, 69 hydrocarbons, 105 ketones, 102 heterocyclic compounds, and 77 lipids and lipid molecules. The categories of volatile organic compounds in serum and feces are similar, so benzene ring compounds, alcohols, aldehydes, hydrocarbons, ketones and heterocyclic compounds are the main volatile organic compounds in biological samples. Therefore, when detecting human or animal samples, it is preferred to select one or more of these categories of reference compounds.

[0056] The concentrations of the reference compound and the internal standard in the mixed reference solution can be adjusted accordingly. A solution of one concentration point can be prepared, or three or a series of concentration points can be selected within the linear range to prepare mixed references of multiple concentrations for use in single-point method, multi-point method or standard curve method to calculate the correction factor. For different biological samples, the concentrations of the reference compound and the internal standard compound in the mixed reference solution can be adjusted accordingly to make their concentrations closer to or include the concentrations in the sample to be tested. At the same time, the amount of the internal standard and reference compound should be sufficient to produce a stable and reproducible signal, and will not adversely affect the performance of the instrument or lead to an enhanced matrix effect; the amount of the internal standard and reference compound should match the expected concentration of volatile organic compounds in the biological sample, and the peaks of the internal standard and reference compound should have a suitable response intensity ratio to the peaks of the sample to be tested.

[0057] S130, adding the mixed internal standard solution to the mixed reference solution and the biological sample respectively to obtain a sample for use in an apparatus.

[0058] Here, the mixed internal standard solution is added to the mixed reference solution and the biological sample so that the mixed internal standard concentrations in the mixed reference solution and the biological sample are the same, thereby obtaining a sample for use in the machine.

[0059] The internal standard and reference compound here can be selected from one or more of the internal standard and reference compound determined in step S110. For example, in some embodiments, the concentration range of the reference compound and the internal standard in the mixed reference is shown in the following table for a single concentration, three concentration points or a series of concentration points:

[0060] Serial number Reference Compounds Linear range Single point concentration 1 Decane 0.00001-0.03 0.01 2 2-Pentanone,3-methyl- 0.00003-0.003 0.0008 3 3-Hexanone,5-methyl- 0.00001-0.01 0.0005 4 Hexanal 0.00001-0.01 0.003 5 4-Heptanone 0.00001-0.01 0.0005 6 Furan,2-pentyl- 0.00001-0.01 0.005 7 p-Cymene 0.00001-0.01 0.003 8 Octanal 0.00001-0.08 0.005 9 Anisole 0.00001-0.0015 0.0005 10 Benzene,1,3-bis(1,1-dimethylethyl)- 0.00001-0.03 0.01 11 Benzaldehyde 0.00003-0.03 0.001 12 1-Octanol 0.00001-0.1 0.001 13 1-Decanol 0.00001-0.05 0.0005 14 Naphthalene,1-methyl- 0.00001-0.03 0.001 15 2-Propenal,2-methyl-3-phenyl- 0.00001-0.03 0.003 16 p-Cresol 0.00001-0.1 0.003 17 Quinoline,2,7-dimethyl- 0.00001-0.1 0.003 18 Eugenol 0.00001-0.05 0.005 19 Phenol, p-tert-butyl- 0.00001-0.1 0.001 20 Indole 0.00001-0.05 0.001 Serial number Internal Standard Linear range Single point concentration 1 Menthol-d4 0.00001-0.05 0.005 2 Benzonitrile-d5 0.00001-0.05 0.0005 3 4-Methyl-phenol-d3 0.00008-0.1 0.008

[0061] Any concentration within the linear range is acceptable, and the preferred concentration is the single-point concentration shown in the table. The single-point concentration is close to the peak area of ​​the corresponding target compound in the sample, which is beneficial to improving the accuracy of the test results and the stability of the test.

[0062] In a feasible embodiment, the samples to be tested need to be pre-treated before being put on the machine. The methods for pre-treating the samples to be tested include: water treatment, acid treatment, salt treatment or simultaneous acid and salt treatment. Water treatment, salt treatment or acid treatment can increase the polarity of the sample to be tested, improve the sensitivity of the detection method to detect different compounds in the sample to be tested, and thus detect more volatile organic compounds. Optionally, the method for pre-treating the samples to be tested is salt treatment. Salt treatment can not only increase the number of volatile organic compounds detected, but also avoid reactions with volatile organic compounds, reducing the impact on the test results. Pre-treatment of samples can effectively improve the sensitivity and accuracy of analysis, protect analytical instruments, improve detection efficiency, ensure sample stability, and adapt to different analytical technical requirements.

[0063] Furthermore, the salt treatment may be carried out by adding saturated sodium chloride to the sample to be tested.

[0064] In a feasible implementation, the operation of the salt treatment step can be: weigh a certain amount of sodium chloride solid into a gas chromatography-mass spectrometry headspace bottle, then use a pipette to measure a certain amount of urine and add it into the gas chromatography-mass spectrometry headspace bottle, tighten the screw cap, and wait for loading after mixing evenly.

[0065] In a feasible implementation, the biological sample can also be pre-processed. For example, when the biological sample is feces, the feces raw material is first subjected to low-temperature freeze-drying treatment, which is conducive to the detection of volatile organic compounds in the feces sample and improves the detection precision, accuracy and stability.

[0066] S140, respectively entering the on-machine samples into a comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometer for measurement to obtain off-machine data, and obtaining reference material data and biological sample data after data processing.

[0067] In an optional embodiment, S130, the samples on the machine are respectively entered into a comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometer for measurement to obtain offline data, and the reference material data and biological sample data are obtained after data processing. The data processing may include: performing peak identification, blank subtraction (pure water solution) and other processing on the mass spectrometry offline data of the mixed reference material solution and the biological sample, respectively, to obtain a compound list, which includes: compound name, one-dimensional retention time (RT_1D), two-dimensional retention time (RT_2D), mass spectrum response (expressed as peak area or peak height, etc.) and other information.

[0068] In a feasible implementation manner, the comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometer model is: Agilent 8890A gas chromatograph + Leco Pegasμs BT 4D TOFMS mass spectrometer + QUADJET GC×GC dual-stage injection modulator.

[0069] In a feasible embodiment, the chromatographic column system is selected from at least one of: chromatographic column 1: DB-5MS (30m×0.25mm×0.25μm) + Rxi-Sli 17MS (2m×0.15mm×0.15μm), chromatographic column 2: DB-Heavy Wax (30m×0.25mm×0.5μm) + Rxi-Sli 5MS (2m×0.15mm×0.15μm) or chromatographic column 3: StabilWax (30m×0.25mm×0.25μm) + Rxi-Sil1MS (2m×0.18mm×0.18μm). Most of the target detection objects are polar compounds, so the selection of a chromatographic column system with polarity is more conducive to the detection and separation of compounds. Optionally or preferably, the chromatographic column system is selected from chromatographic column 1: DB-5MS (30m×0.25mm×0.25μm)+Rxi-Sli 17MS (2m×0.15mm×0.15μm) or chromatographic column 2: DB-Heavy Wax (30m×0.25mm×0.5μm)+Rxi-Sli 5MS (2m×0.15mm×0.15μm). Further, different chromatographic columns can be used to load and test biological samples, and the chromatographic column with better separation effect is preferred.

[0070] In a feasible embodiment, the extraction head is selected from at least one of PDMS-100μm, CAR / PDMS-75μm, PDMS / DVB-65μm or DVB / CAR / PDMS-50 / 30μm. Optionally or preferably, the extraction head is selected from at least one of CAR / PDMS-75μm, PDMS / DVB-65μm or DVB / CAR / PDMS-50 / 30μm. Optionally or preferably, the extraction head is selected from at least one of PDMS / DVB-65μm or DVB / CAR / PDMS-50 / 30μm. Optionally or preferably, the extraction head is DVB / CAR / PDMS-50 / 30μm. The two extraction heads containing a mixture of non-polar and polar materials, 65μm-PDMS / DVB and 50 / 30μm-CAR / PDMS / DVB, have better extraction effects, and are better for the extraction of volatile organic compounds in conventional biological samples.

[0071] In a feasible embodiment, an automatic sampler is used to load the comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometer. Further, the model of the automatic sampler is Agilent L-PAL3. Further, the incubation temperature set by the automatic sampler is: 40°C to 70°C. Optionally or preferably, the incubation temperature set by the automatic sampler is: 40°C, 50°C, 60°C or 70°C. Optionally or preferably, the incubation temperature set by the automatic sampler is: 50°C to 70°C. Optionally or preferably, the incubation temperature set by the automatic sampler is: 55°C to 65°C. Optionally or preferably, the incubation temperature set by the automatic sampler is: 60°C. As the temperature rises, the number of compounds that can be detected in the sample also increases, but at the same time, a reaction may occur when the temperature is too high, which has a certain impact on the target compound. When the incubation temperature set by the automatic sampler is 60°C, the best incubation effect can be achieved.

[0072] Furthermore, the incubation time set for the automatic sampler is: 10min to 45min. Optionally or preferably, the incubation time set for the automatic sampler is: 20min to 45min. Optionally or preferably, the incubation time set for the automatic sampler is: 25min to 40min. Optionally or preferably, the incubation time set for the automatic sampler is: 25min to 35min. Optionally or preferably, the incubation time set for the automatic sampler is: 30min. As the incubation time increases, the number of detected compounds tends to first increase and then decrease. When the incubation time is 30min, the maximum number of compounds can be detected, achieving the best incubation effect.

[0073] Further, the extraction time of the extraction head set by the automatic sampler is: 10min~50min. Optionally or preferably, the extraction time of the extraction head set by the automatic sampler is: 20min~50min. Optionally or preferably, the extraction time of the extraction head set by the automatic sampler is: 30min~50min. Optionally or preferably, the extraction time of the extraction head set by the automatic sampler is: 40min~50min. Optionally or preferably, the extraction time of the extraction head set by the automatic sampler is: 50min. As the extraction time increases, the number of detected compounds increases.

[0074] Further, the injection port analysis time set by the automatic sampler is: 1min to 10min. Optionally or preferably, the injection port analysis time set by the automatic sampler is: 1min to 5min. The injection port analysis time set by the automatic sampler is: 1min. This can achieve a better analysis effect and save detection time.

[0075] Further, the volume of the machine set by the automatic sampler is: 0.1mL~2mL. Optionally or preferably, the volume of the machine set by the automatic sampler is: 0.2mL~1.8mL. Optionally or preferably, the volume of the machine set by the automatic sampler is: 0.5mL~1.8mL. Optionally or preferably, the volume of the machine set by the automatic sampler is: 0.5mL~1.5mL. The volume of the machine is too small, and the number of compounds detected is small. The volume of the machine is too large, exceeding the mass spectrometry response range, and there is a phenomenon of overloading and contaminating the instrument system. Depending on the specific biological sample, the volume of the machine will also be different. For example, the volume of the machine for fecal samples is smaller than that for urine and serum samples, because fecal samples are usually solids, and solutions need to be added when they are put on the machine. If the volume of the added solution is too large, the target volatile organic compounds will be diluted, affecting the test results.

[0076] In a feasible embodiment, the parameters of the full two-dimensional gas chromatograph are: injection port temperature 250°C, non-split injection, carrier gas helium, flow rate 1mL / min, two-dimensional column temperature 5°C higher than one-dimensional furnace temperature, modulator temperature 15°C higher than two-dimensional furnace temperature, temperature program 40°C, hold 3min, increase to 235°C at 4°C / min, hold 8min, modulation cycle 4s to 8s. There are many VOCs components in urine samples, and adjusting the temperature gradient in this way can obtain a better separation effect. Optionally or preferably, the parameters of the full two-dimensional gas chromatograph are: injection port temperature 250°C, non-split injection, carrier gas helium, flow rate 1mL / min, two-dimensional column temperature 5°C higher than one-dimensional furnace temperature, modulator temperature 15°C higher than two-dimensional furnace temperature, temperature program 40°C, hold 3min, increase to 235°C at 4°C / min, hold 8min, modulation cycle 5s. The modulation cycle is crucial. When the modulation cycle is short, some compounds are not resolved and will peak in the next cycle, interfering with detection. Setting the modulation cycle to 5s can achieve better separation effects without causing interference.

[0077] In a feasible embodiment, the parameters of the mass spectrometer are: solvent delay 130s, acquisition frequency 200spectra / s, mass-to-charge ratio range (m / z) 35-550, extraction frequency 32kHz, current 1mA, ion source temperature 250°C, and ionization energy 70eV.

[0078] S150, calculating the correction factor of each reference substance compound in the mixed reference substance solution according to the reference substance data.

[0079] The correction factor can be calculated by single-point method, multi-point method and standard curve method. When using the single-point method, a mixed reference substance with one concentration point is prepared for testing.

[0080] RF (r) =C r *P s / C s *P r , where RF (r) : Correction factor of compound r; C r : The concentration of compound r in the mixed reference substance; P r : mass spectrometric response of the reference compound r in the mixed reference substance; C s : The concentration of the internal standard s of the reference compound r in the mixed reference substance; P s : Mass spectrometric response of the internal standard s of the reference compound r in the mixed reference substance.

[0081] The mass spectrum response can be expressed by peak area, peak height, half peak height, etc., with peak area being preferred.

[0082] When using the multi-point method, prepare multiple concentration points, such as mixed reference materials at high, medium and low concentration points for testing, calculate the correction factors at the high, medium and low concentration points according to the above formula respectively, and take the average of multiple calculations as the final correction factor.

[0083] When using the standard curve method, a series of concentrations of mixed reference substances are prepared for detection, and standard curves of reference substance compound r and its internal standard s are constructed respectively. (r) =k (s) / k (r) , where k (s) is the slope of the standard curve of the internal standard s of compound r, k (r) is the slope of the standard curve of compound r.

[0084] S160, determining the reference compound and the internal standard compound corresponding to the target volatile organic compound in the biological sample.

[0085] The reference compound combination and internal standard compound combination provided in this application are relatively stable. Specifically, by referring to the precision results of the correction factors verified by the analytical method, it can be seen that the intra-day precision of the correction factors of 20 reference compound compounds is good, but the inter-day precision of the correction factors of some reference compound compounds is poor. This may be related to the use characteristics of the extraction head and the extremely low content of VOCs in the biological sample. The extraction head has a certain service life. The number of uses is different, and its adsorption capacity for different VOCs is different. There may also be certain differences between different batches of extraction heads. At the same time, the VOCs content is very low, which further leads to the instability of the correction factor. Therefore, each test should be carried out on the mixed reference solution, RF is calculated, and then the sample to be tested is tested. In this way, the mixed reference solution and the sample to be tested are tested at the same time, which can avoid the influence of factors such as the extraction head on the test results to the greatest extent and ensure the accuracy of the test results. Specifically, the correction factors of n-decane, 2-pentylfuran, 1,3-di-tert-butylbenzene, 4-heptanone, p-cymene, and benzaldehyde measured on different days have large fluctuations (variation exceeds ±30%). When using these reference compounds, the correction factors need to be calculated in each test; the correction factors of other reference compounds measured on the same day and on different days are close (variation within the range of ±30%), which also shows that the correction factors of these compounds are stable and do not need to be calculated every time. Therefore, the preferred reference compounds (corresponding to the internal standard compounds) are: 3- Methyl-2-pentanone (menthol-d4), hexanal (menthol-d4), octanal (menthol-d4), α-methylcinnamaldehyde (menthol-d4), p-methylphenol (menthol-d4), 2,7-dimethylquinoline (menthol-d4), 4-tert-butylphenol (menthol-d4), indole (menthol-d4), ethyl isobutyl ketone (benzonitrile-d5), anisole (benzonitrile-d5), 1-octanol (benzonitrile-d5), 1-decanol (benzonitrile-d5), methylnaphthalene (benzonitrile), eugenol (p-cresol-d3).

[0086] S170, calculating the concentration of the target volatile organic compound according to a concentration formula. The concentration formula is as follows:

[0087] C (n) =P n / P ns' *RF (n) *C ns ,

[0088] Where P n : mass spectrometry response of volatile organic compound n in the biological sample; P ns' : mass spectrometric response of the internal standard s' of the volatile organic compound n in the biological sample; RF (n) : Correction factor corresponding to volatile organic compound n; C ns: The concentration of the internal standard s' of the volatile organic compound n in the biological sample.

[0089] When the mixed reference solution contains a reference compound n that is the same as the target volatile organic compound, the internal standard s of the reference compound n is selected as the internal standard of the volatile organic compound, and the correction factor of the reference compound n is the correction factor RF of the target volatile organic compound. (n) :

[0090] RF (n) =C n *P s' / C s' *P n ,

[0091] In the formula, C n : The concentration of the compound n reference substance in the mixed reference substance solution; P n : mass spectrometric response of compound n reference substance in the mixed reference substance solution; C s' : The concentration of the internal standard s' of compound n in the mixed reference solution, P s' : Mass spectrometric response of the internal standard s' of compound n in the mixed reference solution.

[0092] In a feasible embodiment, when the mixed reference solution does not contain the compound n that is the same as the target volatile organic compound, according to the biological sample data, in the mixed reference combination according to the first predetermined condition, select the compound m that has the closest mass spectrum data and / or chemical structure to the target volatile organic compound and has a reference substance in the mixed reference, and confirm the correction factor RF of the compound m (m) and internal standard s", with the correction factor RF of the compound m (m) and internal standard s" are respectively used as the correction factor RF corresponding to the volatile organic compound n (n) and internal standard s':

[0093] RF (m) =C m *P s” / C s” *P m ,

[0094] In the formula, C m : The concentration of compound m in the mixed reference solution; P m : mass spectrometric response of the reference substance of compound m in the mixed reference substance solution; C s” : The concentration of the internal standard s" of compound m in the mixed reference solution, P s” : Mass spectrometric response of the internal standard s" of compound m in the mixed reference solution.

[0095] In some optional embodiments, the compound m is selected from the biological sample based on the biological sample data, which has the closest mass spectrum data and / or chemical structure to the volatile organic compound n and has a reference substance in the mixed reference substance. This is a reference for selecting the VOC to be tested that does not have the same reference substance compound.

[0096] Among them, the mass spectrum data can be used to determine whether the VOCs to be tested are close to the reference compound, and the closest reference compound can be selected. Specifically, the secondary mass spectrum data can be compared, such as by cosine similarity to determine whether the two are closest, such as by SE Stein et al. [SE Stein, DR Scott. Optimization and testing of massspectral library search algorithms for compound identification. J Am Soc MassSpectrom. 1994 Sep; 5 (9): 859-66.], the cosine similarity score of the secondary mass spectrum data of the VOCs to be tested and each reference compound is calculated, and the reference compound with the highest score is obtained; the primary mass spectrum data, retention time information and secondary mass spectrum data of the VOCs and each reference compound can also be compared respectively, and the closest reference compound can be selected. This method is particularly suitable for situations where there is mass spectrum data information but the compound structure is unknown.

[0097] Determine whether the VOCs are similar to the reference compounds by chemical structure. You can determine whether the VOCs to be tested are similar to the reference compounds by chemical structure; you can also select by compound category and select reference compounds of the same category as the VOCs to be tested. This method is particularly suitable for situations where you know the structure or category of the VOCs to be tested, but do not know the mass spectrum information.

[0098] In some optional embodiments, the step of confirming the correction factor and internal standard corresponding to each volatile organic compound in the biological sample according to the biological sample data includes: when the mixed reference does not contain a reference compound n' that is the same as the volatile organic compound n, selecting a reference compound of the same category as the volatile organic compound n in the biological sample according to the biological sample data; when there are multiple reference compounds of the same category, selecting a reference compound whose number of C, H and / or O atoms is closest to that of the volatile organic compound n; when there is no reference compound of the same category as the volatile organic compound n among the reference compounds, selecting a reference compound with the most stable test result among the reference compounds. For example, if valeraldehyde is detected in a biological sample, that is, the VOCs to be tested is valeraldehyde, then it is selected from the aldehyde reference compounds α-methylcinnamaldehyde, hexanal, benzaldehyde, octanal, decanal, nonanal, and 2-aminobenzaldehyde; further, the difference in the number of atoms such as C and H between the valeraldehyde to be tested and these aldehyde reference compounds is judged, and an aldehyde reference compound with the closest number of atoms is selected, then hexanal is selected as the reference for the VOCs to be tested, that is, the correction factor of hexanal and the corresponding internal standard (menthol-d4) are selected to calculate the content of valeraldehyde in the biological sample.

[0099] The method provided in the present application for quantitatively detecting volatile organic compounds in biological samples by using a comprehensive two-dimensional gas chromatography-mass spectrometry instrument, determines the types of volatile organic compounds in the biological samples by pre-detecting the biological samples, determines the reference substances and internal standards, and when detecting the specific biological samples, pairs the corresponding reference substances with the corresponding volatile organic compounds, and then detects and quantifies the volatile organic compounds in the biological samples based on the correction factors and internal standards of the corresponding reference substances, does not require a large amount of reference substances, reduces the detection cost, and the method is simple to operate.

[0100] With reference to the above implementation contents, in order to make the technical solution of the present application more specific, clear and easy to understand, the technical solution of the present application is now exemplified. However, it should be noted that the contents to be protected by the present application are not limited to the following embodiments.

[0101] Example 1

[0102] Biological sample type: urine sample

[0103] 1. Solution preparation

[0104] 1.1 Mixed reference solution

[0105] The reference substance of the reference substance compound shown in the following table is dissolved in ethanol and diluted with water to prepare a mixed reference substance solution with the concentration shown in the following table.

[0106] Table of concentrations of each reference substance in the mixed reference solution

[0107]

[0108] Note: The concentrations in the above table are obtained by comprehensively considering the test results and linear range of urine samples and are for reference only.

[0109] 1.2 Mixed internal standard solution

[0110] Weigh each internal standard raw material, dissolve it in ethanol and dilute it with water to prepare a mixed internal standard solution: wherein the concentration of benzonitrile-d5 is 0.03 ppm, the concentration of menthol-d4 is 0.3 ppm, and the concentration of p-cresol-d3 is 0.48 ppm.

[0111] Note: The above internal standard concentration is the optimal concentration obtained by experimental optimization, which comprehensively considers the closeness of the mass spectrometric response of the internal standard and the mass spectrometric response of each reference compound and their linear range, and is for reference only.

[0112] 2. Pre-treatment of samples to be tested

[0113] Weigh 0.55g of sodium chloride solid and add it to the headspace bottle, add 1.5mL of the sample to be tested (pure water solution or mixed reference solution or human urine sample), add 10μL of mixed internal standard solution, tighten the bottle cap, and wait for the machine to detect.

[0114] 3. Comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry detection conditions

[0115] 3.1 Autosampler parameters

[0116] Extraction head: 50 / 30μm-CAR / PDMS / DVB;

[0117] The sample incubation temperature was 60°C, the incubation time was 10 min, the extraction time was 30 min, the injection port analysis time was 1 min, and the optimized volume on the machine was 1.5 mL.

[0118] 3.2 Chromatographic parameters

[0119] The column system selected was DB-Heavy Wax (30m×0.25mm×0.5μm)+Rxi-Sli5ms (2m×0.15mm×0.15μm), the injection port temperature was 250℃, non-split injection, the carrier gas was helium, the flow rate was 1ml / min, the two-dimensional column temperature was 5℃ higher than the one-dimensional oven temperature, the modulator temperature was 15℃ higher than the two-dimensional oven temperature, the temperature program was 40℃, maintained for 3min, increased to 235℃ at 4℃ / min, maintained for 8min, and the modulation cycle was 5s.

[0120] 3.3 Mass spectrometry parameters

[0121] The solvent delay was 130 s, the acquisition frequency was 200 spectra / s, the mass-to-charge ratio range (m / z) was 35-550, the extraction frequency was 32 kHz, the current was 1 mA, the ion source temperature was 250 °C, and the ionization energy was 70 eV.

[0122] 4. Comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry detection and data processing methods

[0123] The pure water, mixed reference solution and urine samples after pretreatment were respectively tested by comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry. The mixed reference solution and urine samples were tested three times to obtain mass spectrometry data.

[0124] The mass spectrometry data of the mixed reference solution and urine sample were processed by peak identification, blank subtraction, merging, and outlier removal to obtain the mass spectrometry response of each reference compound and internal standard in the mixed reference solution, and the compound list of the urine sample was obtained, which included compound name, one-dimensional retention time (RT_1D), two-dimensional retention time (RT_2D), mass spectrometry response and other information.

[0125] Representative spectra of urine samples detected by comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry are shown below: Figure 1 and Figure 2 shown.

[0126] The correction factor is calculated using the mass spectrometry data of the mixed standard solution.

[0127] RF (r) =C r *P s / C s *P r , RF (r) C: The correction factor of the reference substance r in the mixed reference substance solution; r : The concentration of the reference substance r in the mixed reference substance solution; P r : mass spectrometric response of the reference substance r in the mixed reference substance solution; C rs : The concentration of the internal standard s of the reference substance r in the mixed reference substance solution, P rs : The mass spectrometer response of the internal standard s of the reference substance r in the mixed reference substance solution. The calculation results are shown in Table 4:

[0128] Table 4:

[0129]

[0130] Note: The correction factors in the above table are for reference only.

[0131] The content of VOCs in urine is calculated based on the test data of urine samples.

[0132] A total of 1,141 compounds were identified using the instrument’s built-in NIST database.

[0133] According to the correction factors shown in Table 4 and the corresponding relationship shown in Table 3, the corresponding concentration of volatile organic compounds is calculated.

[0134] When there is a reference substance in the mixed reference substance solution, the concentration of volatile organic compound n is: C (n) =P n / P ns' *RF (n) , where P n : mass spectrometry response of volatile organic compound n in the urine sample; P ns' : mass spectrometric response of the internal standard s' of the volatile organic compound n in the urine sample; RF (n) : Correction factor corresponding to volatile organic compound n.

[0135] When there is no reference substance in the mixed reference substance solution for volatile organic compound n', select the reference substance compound of the same category as the 20 compounds in Table 4 as the reference (m); when there are multiple compounds of the same category, select the reference substance compound with the closest number of C and H as the reference (m); when there is no reference substance and no reference substance of the same category, select the reference substance compound with the closest number of C, H, O, and N as the reference (m). Use the correction factor (RF (m) ) and the mass spectrometric response of the corresponding internal standard (s”) in urine samples (P s” ) Calculate the concentration of volatile organic matter n': C (n') =P n' / P s” *RF (m) (P s” is the mass spectrometer response of the internal standard s” of m in the urine sample).

[0136] The test results of Example 1 are shown in the following table (only CAS number and corresponding concentration are shown) and Figures 2 to 3 As shown:

[0137]

[0138]

[0139]

[0140]

[0141]

[0142]

[0143]

[0144] Example 2

[0145] Biological sample type: serum sample

[0146] 1. Solution preparation

[0147] 1.1 Mixed reference solution

[0148] The reference substance of the reference substance compound shown in the following table is dissolved in ethanol and diluted with water to prepare a mixed reference substance solution with the concentration shown in the following table.

[0149] Table of concentrations of each reference substance in the mixed reference solution

[0150]

[0151] Note: The concentrations in the above table are obtained by comprehensively considering the test results and linear range of serum samples and are for reference only.

[0152] 1.2 Mixed internal standard solution

[0153] Weigh each internal standard raw material, dissolve it in ethanol and dilute it with water to prepare a mixed internal standard solution: wherein the concentration of benzonitrile-d5 is 0.03 ppm, the concentration of menthol-d4 is 0.3 ppm, and the concentration of p-cresol-d3 is 0.48 ppm.

[0154] Note: The internal standard concentrations in the above table are the optimal concentrations obtained through experimental optimization, taking into account the closeness of the mass spectrometric response of the internal standard and the mass spectrometric response of each reference compound and their linear range, and are for reference only.

[0155] 2. Pre-treatment of samples to be tested

[0156] Take 100 μL of the sample to be tested (pure water, mixed reference solution or serum sample) into the headspace bottle, add 500 μL of pure water, add 10 μL of internal standard solution, tighten the bottle cap, and wait for the machine to detect.

[0157] 3. Comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry detection conditions

[0158] 3.1 Autosampler parameters

[0159] Extraction head: 65μm-PDMS / DVB;

[0160] The sample incubation temperature was 60°C, the incubation time was 10 min, the extraction time at the extraction head was 30 min, and the analysis time at the injection port was 1 min.

[0161] 3.2 Chromatographic parameters

[0162] One-dimensional chromatographic column: DB-HeavyWax (30m×0.25mm×0.5μm); two-dimensional chromatographic column: Rxi-Sli5ms (2m×0.15mm×0.15μm).

[0163] The injection port temperature was 250°C, non-split injection, carrier gas was helium, flow rate was 1 mL / min, the second-dimensional column temperature was 5°C higher than the first-dimensional oven temperature, the modulator temperature was 15°C higher than the second-dimensional oven temperature, the temperature rising program was 40°C, maintained for 4 min, increased to 150°C at 5°C / min, maintained for 5 min, increased to 155°C at 0.5°C / min, maintained for 1 min, increased to 235°C at 10°C / min, maintained for 16 min, and the modulation cycle was 8 s.

[0164] 3.3 Mass spectrometry parameters

[0165] The solvent delay was 130 s, the acquisition frequency was 200 spectra / s, the mass-to-charge ratio range (m / z) was 35-550, the extraction frequency was 32 kHz, the current was 1 mA, the ion source temperature was 250 °C, and the ionization energy was 70 eV.

[0166] 4. Comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry detection and data processing methods

[0167] The pure water, mixed reference solution and serum samples after pretreatment were respectively tested by comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry. The mixed reference solution and serum samples were tested three times to obtain mass spectrometry data.

[0168] Representative spectra of serum samples detected by comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry are shown in Figure 2. Figure 3 and Figure 4 shown.

[0169] The mass spectrometry data of the mixed reference solution and serum samples were processed by peak identification, blank subtraction, merging, etc. to obtain the mass spectrometry responses of each reference compound and internal standard in the mixed reference solution, and the compound list of the urine sample was obtained. The compound list included: compound name, one-dimensional retention time (RT_1D), two-dimensional retention time (RT_2D), mass spectrometry response and other information.

[0170] The correction factor is calculated by the mass spectrometry data of the mixed reference solution. The calculation results are shown in Table 4: Table 4:

[0171]

[0172] Note: The correction factors in the above table are for reference only.

[0173] The content of VOCs in serum samples was calculated based on the test data.

[0174] A total of 680 compounds were identified using the instrument’s built-in NIST database.

[0175] When there is a reference substance in the mixed reference substance solution, the concentration of volatile organic compound n is: C (n) =P n / P ns' *RF (n) , where P n : mass spectrometry response of volatile organic compound n in the urine sample; P ns' : mass spectrometric response of the internal standard s' of the volatile organic compound n in the urine sample; RF (n) : Correction factor corresponding to volatile organic compound n.

[0176] When there is no reference substance in the mixed reference substance solution, the reference substance compound with the most similar chemical structure among the 20 compounds in Table 4 is selected as the reference (m). The correction factor (RF (m) ) and the mass spectrometry response (P s” ) Calculate the concentration of volatile organic matter n': C (n') =P n' / P s” *RF (m) (P s” is the mass spectrometer response of the internal standard s” of m in the serum sample).

[0177] The test results of Example 2 are shown in the following table (only CAS number and corresponding concentration are shown) and Figures 4 to 5 As shown:

[0178]

[0179]

[0180]

[0181]

[0182]

[0183] Example 3

[0184] Biological sample type: stool sample

[0185] 1. Solution preparation

[0186] 1.1 Mixed reference solution

[0187] The reference substance of the reference substance compound shown in the following table is dissolved in ethanol and diluted with water to prepare a mixed reference substance solution with the concentration shown in the following table.

[0188] Table of concentrations of each reference substance in the mixed reference solution

[0189]

[0190]

[0191] 1.2 Mixed internal standard solution

[0192] Weigh each internal standard raw material, dissolve it in ethanol and dilute it with water to prepare a mixed internal standard solution. Among them, the concentration of benzonitrile-d5 is 0.03ppm, the concentration of menthol-d4 is 0.3ppm, and the concentration of p-cresol-d3 is 0.48ppm.

[0193] Providing fecal raw materials, and pre-treating the fecal raw materials to obtain a fecal sample;

[0194] (3) Fecal samples to be tested: The fecal samples of volunteers were collected, packaged, and freeze-dried for 48 hours. 30 mg of the dried fecal sample was placed in a headspace bottle, 600 μL of water was added, 10 μL of internal standard solution was added, and the bottle cap was tightened for testing;

[0195] Reference sample to be tested: Take 600 μL of mixed reference solution and place it in a headspace bottle, add 10 μL of internal standard solution, tighten the bottle cap, and wait for the machine to test;

[0196] Blank sample: Take 600μL of water and place it in the headspace bottle, add 10μL of internal standard solution, tighten the bottle cap, and wait for the machine to detect.

[0197] Comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry detection conditions, equipment model is Agilent 8890A gas chromatograph + Leco Pegasμs BT 4D TOFMS mass spectrometer + QUADJET GC×GC dual-stage jet modulator:

[0198] 1. Automatic injection parameters

[0199] Extraction head: 65μm-PDMS / DVB

[0200] The sample incubation temperature was 60°C, the incubation time was 10 min, the extraction time at the extraction head was 30 min, and the analysis time at the injection port was 1 min.

[0201] 2. Chromatographic conditions

[0202] Column system selection: DB-Heavy Wax (30m×0.25mm×0.5μm); Rxi-sli5ms (2m×0.15mm×0.15μm).

[0203] The injection port temperature was 250°C, non-split injection, carrier gas was helium, flow rate was 1 mL / min, the second-dimensional column temperature was 5°C higher than the first-dimensional oven temperature, the modulator temperature was 15°C higher than the second-dimensional oven temperature, the temperature rising program was 40°C, maintained for 4 min, increased to 150°C at 5°C / min, maintained for 5 min, increased to 155°C at 0.5°C / min, maintained for 1 min, increased to 235°C at 10°C / min, maintained for 16 min, and the modulation cycle was 4s.

[0204] 3. Mass spectrometry conditions

[0205] The solvent delay was 130 s, the acquisition frequency was 200 spectra / s, the mass-to-charge ratio (m / z) range was 35-550, the extraction frequency was 32 kHz, the current was 1 mA, the ion source temperature was 250 °C, and the ionization energy was 70 eV.

[0206] The mass spectrometry data of the calibration samples and fecal samples were processed by peak identification and blank subtraction to obtain a compound list, which included compound name, one-dimensional retention time (RT_1D), two-dimensional retention time (RT_2D), mass spectrometry response and other information.

[0207] Representative spectra of fecal samples detected by comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry are shown in Figure 2. Figure 5 and Figure 6 shown.

[0208] The calibration factor is calculated by calibrating the mass spectrometer data of the sample, as shown in Table 4:

[0209] Table 4:

[0210]

[0211]

[0212] The VOCs content in stool samples is calculated based on the test data.

[0213] A total of 910 compounds were identified using the NIST database provided by the instrument, and the content of each compound was calculated in the same manner as in Example 1.

[0214] The test results of Example 3 are shown in the following table (only CAS number and corresponding concentration are shown) and Figure 6 to Figure 7 As shown:

[0215]

[0216]

[0217]

[0218]

[0219]

[0220]

[0221]

[0222] It can be seen from the results of the above embodiments that the method for quantitatively detecting VOCs in serum samples by comprehensive two-dimensional gas chromatography-mass spectrometry provided in the present application can simultaneously detect multiple VOCs in biological samples, including serum, urine and feces. Although there are certain differences in the VOCs present in different biological samples, including differences in quantity, type and concentration, etc. However, the detection method provided in the present application can use the same reference compound combination and internal standard compound combination for detection, has good consistency and repeatability, is conducive to laboratory sample analysis, and is conducive to a wide range of applications.

[0223] Validation of analytical methods:

[0224] As an example, the validation results of the method for quantitatively detecting VOCs in serum samples by comprehensive two-dimensional gas chromatography-mass spectrometry provided in Example 2 are as follows. The validation items include specificity, linearity and range, precision and accuracy:

[0225] 1. Exclusiveness verification;

[0226] Specificity is the ability to detect and distinguish the target substance from other similar substances (such as internal standard compounds, isomers, etc.), and examines whether there is interference between the blank and the sample at the peak time of the analyte and the internal standard compound. In Example 2, the results of the serum sample and the blank sample (pure water solution) were compared on the machine, and the mass spectrometry response comparison results are shown in the following table:

[0227] Serial number Compound Name Serum peak area Blank peak area 1 Decane 4.21E+07 6.32E+08 2 2-Pentanone,3-methyl- / 1.98E+05 3 Disulfide, dimethyl / 8.33E+04 4 3-Hexanone,5-methyl- / 1.74E+05 5 Hexanal 8.47E+06 1.33E+07 6 4-Heptanone / 3.14E+07 7 Furan,2-pentyl- 6.46E+07 5.65E+07 8 trans-β-Ocimene 5.83E+06 3.40E+05 9 p-Cymene 5.54E+04 3.74E+07 10 Octanal 3.11E+06 3.76E+06 11 Anisole / 6.05E+04 12 Dimethyl trisulfide / / 13 Benzene,1,3-bis(1,1-dimethylethyl)- 2.03E+07 3.64E+07 14 Benzaldehyde 1.44E+06 2.91E+07 15 1-Octanol 8.76E+05 / 16 1-Decanol 1.49E+05 5.61E+05 17 Naphthalene,1-methyl- / 2.19E+06 18 2-Propenal,2-methyl-3-phenyl- 4.81E+04 19 p-Cresol 8.76E+05 1.28E+06 20 Quinoline,2,7-dimethyl- / / 21 Eugenol / / 22 Phenol, p-tert-butyl- 1.41E+06 8.33E+05 23 Indole 1.49E+05 9.83E+05 24 4-Methyl-2-pentanone-d5 / / 25 Dimethyl Trisulfide-d3 / / 26 Benzonitrile-d5 / / 27 Menthol-d4 / / 28 4-Methyl-phenol-d3 / /

[0228] The peaks and response interference of substances were analyzed. Most substances were not detected in the blank sample, indicating that these substances did not have blank interference. Mass spectrometry responses were detected for some substances, but the responses of the substances were low, which did not affect the quantification of the substances and could be ignored. For substances with interference in the sample, given the sensitivity of the full two-dimensional instrument, the interference could not be eliminated. Later, the single concentration point was increased by the substance, so that the mass spectrometry response of the substance at the single concentration point reached more than 3 times that of the blank sample.

[0229] 2. Linearity and range verification;

[0230] The standard curve or standard working curve was prepared according to the standard method, and the linear regression analysis was performed using the least squares method.

[0231] The reference compound and internal standard compound shown in the table below were taken to prepare mixed solutions of 5 series of concentrations, and the samples were processed and tested according to the sample pretreatment and comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry detection conditions described in Example 2. The test data were processed to construct a linear relationship curve between mass spectrometry response and concentration. The results are shown in the following table:

[0232]

[0233]

[0234] From the results in the above table, it can be seen that the compounds selected as reference compounds and internal standard compounds in this application have better linearity and linear range than other common organic volatiles in serum. The linear correlation coefficient of the linear regression equation of the compounds selected as reference compounds and internal standard compounds in this application is not less than 0.99, and the linear range is wide. The linear relationship of each reference compound is good and the linear range is wide, which can be used as the reference compound or relative reference compound and internal standard compound for most organic volatiles in serum samples.

[0235] 3. Precision verification:

[0236] In the early stage of serum sample detection and analysis, multiple substances were not detected in the serum samples. The spiked samples were prepared for detection by spiking method. The specific spiked concentrations are shown in the table. The precision results of the detection results of each compound were calculated.

[0237]

[0238] 3.1 Precision of serum sample spikes

[0239] According to the above table, the reference substance was added to the serum sample to prepare the serum spiked sample, which was processed and detected by comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry according to the method for determining the content of organic volatiles in serum in Example 2, and then tested again, in parallel for 3 times, for 3 consecutive days, and the mass spectrometry response and RSD (Relative Standard Deviation) of the standard substance within the day were calculated. The specific results are shown in the following table:

[0240] Intraday n=3, d=1; Interday n=9, d=3

[0241]

[0242]

[0243] From the results in the table above, we can see that the RSD of intra-day precision of all compounds is below 15%, and the intra-day precision is good. Except for Dimethyl trisulfide, Disulfide, dimethyl and Dimethyl Trisulfide-d3, the RSD of inter-day precision of other compounds is below 30%, and the inter-day precision is good. Dimethyl trisulfide, Disulfide, dimethyl and Dimethyl Trisulfide-d3 have poor inter-day precision, and it is difficult to ensure the stability of the test results when used as a control, so they are removed from the reference compounds.

[0244] 3.2 Precision of serum samples

[0245] Serum samples were taken to determine the VOCs content therein. The samples were processed and detected by comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry according to the method for determining the content of volatile organic compounds in serum described in Example 2. Five replicates were set in parallel and the detection was continued for 3 days. The RSD of the test results was calculated. The precision results are shown in the following table:

[0246]

[0247] Among them, n=5, d=1 within the day; n=15, d=3 between days.

[0248] As can be seen from the above table, the RSD of the intra-day test results and the RSD of the inter-day test results of the serum samples were both below 30%, indicating that the precision of the detection method was good.

[0249] 3.3 Correction factor precision

[0250] A mixed reference solution was prepared according to the method of Example 2 and tested, with three samples prepared in parallel on the same day and one sample prepared on three different days for testing. The correction factor was calculated according to the corresponding relationship between the reference compound and the internal standard in Example 2.

[0251] The intra-day precision results are as follows:

[0252]

[0253] The inter-day precision results are as follows:

[0254]

[0255]

[0256] It can be seen from the above table that the correction factors of the compounds measured on the same day have good repeatability (the change does not exceed ±30%), and the correction factors of some compounds measured on different days fluctuate greatly (the change exceeds ±30%), specifically: n-decane, 2-pentylfuran, 1,3-di-tert-butylbenzene, 4-heptanone, p-cymene, and benzaldehyde.

[0257] 4. Accuracy

[0258] In order to verify the accuracy of the method, we conducted a spike recovery test, tested according to the method of Example 2, and calculated the recovery. The recovery results are as follows:

[0259]

[0260] From the results in the table, it can be seen that the recovery rate is in the range of 50% to 150%, and the accuracy of the method is good. Among them, the recovery rates of 3-methyl-2-pentanone, p-methylphenol, 2,7-dimethylquinoline, 4-tert-butylphenol, ethyl isobutyl ketone, 4-heptanone, p-cymene, anisole, 1-decanol, and methylnaphthalene are in the range of 80% to 120%, with high accuracy.

[0261] It should be noted that the method for quantitatively detecting volatile organic compounds in biological samples by using a comprehensive two-dimensional gas chromatography-mass spectrometry of the present invention can obtain accurate quantitative results for volatile organic compounds n with reference compounds of the same structure in biological samples. For volatile organic compounds n' without reference compounds of the same structure in biological samples, one m in the reference compound can be selected as a reference, and the content of n' in the biological sample can be calculated using the correction factor of m and the internal standard to obtain a quantitative result for reference. The closer the chemical structure of n' is to m, the more accurate the quantitative result. The reference compounds and internal standard compounds selected by the present invention are stable and reliable. When used as a reference, more stable test results can be obtained, so that the test results of different batches of biological samples are consistent, which is conducive to the comparative study of large batches of samples. The method of the present invention can be applied to the discovery of differential metabolites. For example, when it is necessary to find differential metabolites between healthy people and lung cancer patients, the method of the present invention can be used to detect serum, urine or feces samples of large batches of healthy people and lung cancer patients, respectively, to obtain qualitative and quantitative data of a large number of compounds, and then find the differential metabolites of the two through statistical analysis.

[0262] In summary, the method for quantitatively detecting volatile organic compounds in biological samples using a comprehensive two-dimensional gas chromatography-mass spectrometry instrument provided in the present application does not require a large amount of reference substances during sample detection, thereby reducing detection costs. The method is also simple to operate, time-saving, and stable, and is suitable for large-scale applications.

[0263] The basic concepts have been described above. Obviously, for those skilled in the art, the above detailed disclosure is only for example and does not constitute a limitation of this specification. Although not explicitly stated here, those skilled in the art may make various modifications, improvements and corrections to this specification. Such modifications, improvements and corrections are suggested in this specification, so such modifications, improvements and corrections still belong to the spirit and scope of the exemplary embodiments of this specification.

[0264] At the same time, this specification uses specific words to describe the embodiments of this specification. For example, "one embodiment", "an embodiment", and / or "some embodiments" refer to a certain feature, structure or characteristic related to at least one embodiment of this specification. Therefore, it should be emphasized and noted that "one embodiment" or "an embodiment" or "an alternative embodiment" mentioned twice or more in different positions in this specification does not necessarily refer to the same embodiment. In addition, certain features, structures or characteristics in one or more embodiments of this specification can be appropriately combined.

[0265] In addition, unless explicitly stated in the claims, the order of the processing elements and sequences described in this specification, the use of alphanumeric characters, or the use of other names are not intended to limit the order of the processes and methods of this specification. Although the above disclosure discusses some invention embodiments that are currently considered useful through various examples, it should be understood that such details are only for illustrative purposes, and the attached claims are not limited to the disclosed embodiments. On the contrary, the claims are intended to cover all modifications and equivalent combinations that are consistent with the essence and scope of the embodiments of this specification.

[0266] Similarly, it should be noted that in order to simplify the description disclosed in this specification and thus help understand one or more embodiments of the invention, in the above description of the embodiments of this specification, multiple features are sometimes combined into one embodiment, figure or description thereof. However, this disclosure method does not mean that the features required by the subject matter of this specification are more than the features mentioned in the claims. In fact, the features of the embodiments are less than all the features of the single embodiment disclosed above.

[0267] In some embodiments, numbers describing the number of components and attributes are used. It should be understood that such numbers used in the description of the embodiments are modified by the modifiers "about", "approximately" or "substantially" in some examples. Unless otherwise specified, "about", "approximately" or "substantially" indicate that the numbers are allowed to vary by ±20%. Accordingly, in some embodiments, the numerical parameters used in the specification and claims are approximate values, which may change according to the required features of individual embodiments. In some embodiments, the numerical parameters should take into account the specified significant digits and adopt the general method of retaining digits. Although the numerical domains and parameters used to confirm the breadth of their range in some embodiments of this specification are approximate values, in specific embodiments, the setting of such numerical values ​​is as accurate as possible within the feasible range.

[0268] Each patent, patent application, patent application publication, and other materials, such as articles, books, specifications, publications, documents, etc., cited in this specification are hereby incorporated by reference in their entirety. Except for application history documents that are inconsistent with or conflicting with the contents of this specification, documents that limit the broadest scope of the claims of this specification (currently or later attached to this specification) are also excluded. It should be noted that if the descriptions, definitions, and / or use of terms in the materials attached to this specification are inconsistent or conflicting with the contents described in this specification, the descriptions, definitions, and / or use of terms in this specification shall prevail.

[0269] Finally, it should be understood that the embodiments described in this specification are only used to illustrate the principles of the embodiments of this specification. Other variations may also fall within the scope of this specification. Therefore, as an example and not a limitation, alternative configurations of the embodiments of this specification may be considered consistent with the teachings of this specification. Accordingly, the embodiments of this specification are not limited to the embodiments explicitly introduced and described in this specification.

Claims

1. A method for quantitatively detecting volatile organic compounds in biological samples using a comprehensive two-dimensional gas chromatography-mass spectrometer, characterized in that: The method comprises the following steps: Determine the reference compound combination and the internal standard compound combination based on the biological sample; Providing a mixed reference solution including the reference compound combination, a mixed internal standard solution including the internal standard compound combination, and a biological sample; Adding the mixed internal standard solution to the mixed reference solution and the biological sample respectively to obtain a sample for use in an apparatus; The samples on the machine are respectively put into a comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometer for measurement to obtain off-machine data, and after data processing, reference material data and biological sample data are obtained; Calculating a correction factor for each reference substance compound in the mixed reference substance solution according to the reference substance data; Determining reference compounds and internal standard compounds corresponding to the target volatile organic compounds in the biological sample; The concentration of the target volatile organic compound is calculated according to a concentration formula, and the concentration formula is as follows: C (n) =P n / P ns' *RF (n) *C ns ; In the formula, C (n) : The concentration of target volatile organic compounds; P n : Mass spectrometry response of target volatile organic compounds; P ns' : Mass spectrometric response of the internal standard compound corresponding to the target volatile organic compound; RF (n) : Correction factor of the reference compound corresponding to the target volatile organic compound; C ns : The concentration of the internal standard compound corresponding to the target volatile organic compound.

2. The method for quantitatively detecting volatile organic compounds in biological samples by comprehensive two-dimensional gas chromatography-mass spectrometry according to claim 1, characterized in that: The operation of determining the reference compound and the internal standard compound corresponding to the target volatile organic compound in the biological sample comprises the following steps: When the mixed reference solution contains a first reference compound that is the same as the target volatile organic compound, the internal standard of the first reference compound is selected as the internal standard of the target volatile organic compound, and the correction factor of the first reference compound is the correction factor of the target volatile organic compound.

3. The method for quantitatively detecting volatile organic compounds in biological samples by comprehensive two-dimensional gas chromatography-mass spectrometry according to claim 1, characterized in that: The operation of determining the reference compound and the internal standard compound corresponding to the target volatile organic compound in the biological sample comprises the following steps: When the mixed reference solution does not contain a compound identical to the target volatile organic compound, according to the biological sample data, in the mixed reference combination according to a first predetermined condition, a compound whose mass spectrum data and / or chemical structure is closest to the target volatile organic compound is selected as the second reference compound, then the internal standard of the second reference compound is the internal standard of the target volatile organic compound, and the correction factor of the second reference compound is the correction factor of the target volatile organic compound.

4. The method for quantitatively detecting volatile organic compounds in biological samples by comprehensive two-dimensional gas chromatography-mass spectrometry according to claim 1, characterized in that: Determining the reference compound and the internal standard compound according to the biological sample comprises the following steps: According to the target organic volatiles, obtain pre-selected reference substances and pre-selected internal standards; Taking the preselected reference substance and the preselected internal standard, diluting them step by step to prepare mixed solutions with a series of concentrations; The mixed solution is placed in the comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometer for measurement to obtain mass spectrometry data. According to the mass spectrometer offline data, respectively constructing a linear relationship curve between the concentration and mass spectrometer response of each preselected reference compound and preselected internal standard; Calculate the correction factor for each preselected reference and each preselected internal standard separately; The reference compound combination and the internal standard compound combination are determined based on the linear relationship curve and the correction factor.

5. The method for quantitatively detecting volatile organic compounds in biological samples by comprehensive two-dimensional gas chromatography-mass spectrometry according to claim 4, characterized in that: The operation of determining the reference compound combination and the internal standard compound combination according to the linear relationship curve and the correction factor comprises the following steps: Preselected reference substances and preselected internal standards whose linear relationship curves and correction factors satisfy preselected conditions are retained, wherein the preselected conditions include: a linear correlation coefficient of the linear relationship curve>0.99 and at least one correction factor within the range of 0.1-10.

6. The method for quantitatively detecting volatile organic compounds in biological samples by comprehensive two-dimensional gas chromatography-mass spectrometry according to claim 5, characterized in that: The operation of determining the reference compound and the internal standard compound according to the linear relationship curve and the correction factor also includes the following steps: The internal standard compound corresponding to the reference compound is determined according to the preset value of the correction factor.

7. The method for quantitatively detecting volatile organic compounds in biological samples by comprehensive two-dimensional gas chromatography-mass spectrometry according to claim 1, characterized in that: The mixed reference substance solution includes one or more of a benzene ring compound reference substance, an aldehyde reference substance, an alcohol reference substance, a ketone reference substance, a hydrocarbon reference substance, a heterocyclic compound reference substance and a lipid compound reference substance.

8. The method for quantitatively detecting volatile organic compounds in biological samples by comprehensive two-dimensional gas chromatography-mass spectrometry according to claim 7, characterized in that: The benzene ring compound reference substance is selected from at least one of eugenol, p-methylphenol, 4-tert-butylphenol, 2-methoxy-4-vinylphenol, phenol, p-isopropyltoluene, 1,3-di-tert-butylbenzene, methylnaphthalene, p-cymene and anisole; The aldehyde reference substance is selected from at least one of α-methylcinnamaldehyde, hexanal, benzaldehyde, octanal, decanal, nonanal and 2-aminobenzaldehyde; The alcohol reference substance is selected from at least one of 1-decanol, 1-octanol, tetradecanol, cis-9-hexadecenol and cholesterol; The ketone reference substance is selected from at least one of 4-heptanone, 3-methyl-2-pentanone, ethyl isobutyl ketone, 2-pentanone, 2-nonanone and cyclohexanone; The hydrocarbon reference substance is selected from at least one of trans-2-decenoic acid and n-decane; The heterocyclic compound reference substance is selected from at least one of 2,5-dimethylpyrazine, N-ethyl pyridine bromide, proline, indole, 2,7-dimethylquinoline and 2-n-pentylfuran; The ester compound reference substance is selected from at least one of methyl palmitate and ethyl acetate.

9. The method for quantitatively detecting volatile organic compounds in biological samples by comprehensive two-dimensional gas chromatography-mass spectrometry according to claim 8, characterized in that: The internal standard compound in the mixed reference substance is selected from at least one of menthol-d4, 4-methyl-2-pentanone-d5, p-cresol-d3 and benzonitrile-d5.

10. The method for quantitatively detecting volatile organic compounds in biological samples by comprehensive two-dimensional gas chromatography-mass spectrometry according to claim 9, characterized in that: The corresponding relationship between reference compound and internal standard compound is shown in the following table: 。 11. The method for quantitatively detecting volatile organic compounds in biological samples by comprehensive two-dimensional gas chromatography-mass spectrometry according to claim 1, characterized in that: The biological sample is selected from at least one of urine, serum and feces.

12. The method for quantitatively detecting volatile organic compounds in biological samples by comprehensive two-dimensional gas chromatography-mass spectrometry according to claim 1, characterized in that: The comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometer model is: Agilent 8890A gas chromatograph + Leco Pegasμs BT 4D TOFM S mass spectrometer + QUADJET GC×GC dual-stage injection modulator.